Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

News Release

Printer Friendly Version View printer-friendly version
Charles River Laboratories to Present at Jefferies and William Blair Conferences

WILMINGTON, Mass.--(BUSINESS WIRE)--Jun. 4, 2018-- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Jefferies 2018 Global Healthcare Conference in New York, New York, on Wednesday, June 6th, at 11:00 a.m. ET, and at the William Blair 38th Annual Growth Stock Conference in Chicago, Illinois, on Wednesday, June 13th, at 10:00 a.m. CT (11:00 a.m. ET). Management will present an overview of Charles River’s strategic focus and business developments.

A live webcast of each presentation will be available through a link that will be posted on the Investor Relations section of the Charles River website at ir.criver.com. A webcast replay will be accessible through the same website after each presentation and will remain available for approximately two weeks.

About Charles River

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.

Source: Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc.
Investor Relations Contact:
Todd Spencer, 781-222-6455
Corporate Vice President, Investor Relations
todd.spencer@crl.com

Stock Quote

CRL (common)
Price
$120.01
Change (%)
- 0.24 (0.20%)
Volume
242,191
Exchange
NYSE
Data as of 12/18/18 4:02 p.m. ET
Data provided by Nasdaq.
Minimum 15 minutes delayed.

Refresh Quote

Investor Hotline

877-567-6CRL (6275)